Breaking News Instant updates and real-time market news.

UBER

Uber

$51.21 /

-1.79 (-3.38%)

, PTON

Peloton

$82.61 /

-14.26 (-14.72%)

08:55
05/06/21
05/06
08:55
05/06/21
08:55

Notable open interest changes for May 6th

Wednesday's total option volume of 32.9 million contracts resulted in net open interest growth of 3.46 million calls and 3.57 million puts. Uber (UBER), Peloton Interactive (PTON), Apple (AAPL) and Advanced Micro (AMD) saw the greatest growth. Top five new positions opened include 50k EQT Corporation (EQT) Jan-23 25 calls, 48k Sabre (SABR) Apr-22 17 calls, 30k Uber (UBER) Jan-22 42 puts, 27k Ford (F) Sep-21 8 puts and 27k Uber (UBER) Jan-22 65 calls.

UBER

Uber

$51.21 /

-1.79 (-3.38%)

PTON

Peloton

$82.61 /

-14.26 (-14.72%)

AAPL

Apple

$128.16 /

+0.22 (+0.17%)

AMD

AMD

$77.85 /

-0.77 (-0.98%)

  • 06

    May

  • 10

    May

  • 17

    May

  • 19

    May

  • 24

    May

  • 08

    Jan

UBER Uber
$51.21 /

-1.79 (-3.38%)

05/06/21 JPMorgan
JPMorgan boosts Uber target to $74 on continued mobility recovery
05/06/21 Deutsche Bank
Uber price target raised to $85 from $82 at Deutsche Bank
05/06/21 Piper Sandler
Uber price target lowered to $55 from $58 at Piper Sandler
05/05/21 Cowen
Department of Labor comments incrementally encouraging for Uber/Lyft, says Cowen
PTON Peloton
$82.61 /

-14.26 (-14.72%)

05/05/21 BofA
Peloton downgraded to Neutral after 'thesis changing' recalls at BofA
05/05/21 BofA
Peloton downgraded to Neutral from Buy at BofA
05/05/21 BMO Capital
BMO Capital continues to worry Peloton shares will catch down to fundamentals
05/05/21 JPMorgan
JPMorgan sees Peloton shares remaining under pressure
AAPL Apple
$128.16 /

+0.22 (+0.17%)

05/05/21 Bernstein
Bernstein sees modest financial consequence to Apple even with adverse rulings
05/04/21 Morgan Stanley
Apple Services estimate trimmed at Morgan Stanley after April App Store data
05/04/21 Needham
Cirrus Logic upgraded to Buy from Hold at Needham
05/03/21 Evercore ISI
Apple's App Store developer revenue growth slowed in April, says Evercore ISI
AMD AMD
$77.85 /

-0.77 (-0.98%)

04/28/21 Northland
AMD price target raised to $116 from $96 at Northland
04/28/21 Susquehanna
AMD price target raised to $125 from $115 at Susquehanna
04/28/21 Raymond James
AMD price target raised to $110 from $100 at Raymond James
04/28/21 Mizuho
AMD price target raised to $107 from $105 at Mizuho

TODAY'S FREE FLY STORIES

Recommendations
Abiomed confident in near-term business recovery, says Piper Sandler » 05:02
06/18/21
06/18
05:02
06/18/21
05:02
ABMD

Abiomed

$312.81 /

+10.1 (+3.34%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABMD Abiomed
$312.81 /

+10.1 (+3.34%)

ABMD Abiomed
$312.81 /

+10.1 (+3.34%)

06/08/21 Piper Sandler
Tweet suggests Abiomed study trending in right direction, says Piper Sandler
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Piper Sandler
Abiomed earnings selloff a buying opportunity, says Piper Sandler
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
ABMD Abiomed
$312.81 /

+10.1 (+3.34%)

ABMD Abiomed
$312.81 /

+10.1 (+3.34%)

Recommendations
Adobe price target raised to $600 from $550 at Oppenheimer » 05:00
06/18/21
06/18
05:00
06/18/21
05:00
ADBE

Adobe

$551.22 /

+8.16 (+1.50%)

Oppenheimer analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

04:55 Today Jefferies
Adobe price target raised to $660 from $630 at Jefferies
06/14/21 Jefferies
Adobe price target raised to $630 from $560 at Jefferies
05/24/21 Mizuho
Mizuho starts digital creativity and productivity 'titan' Adobe at Buy
05/24/21 Mizuho
Adobe initiated with a Buy at Mizuho
ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

Upgrade
National Health upgraded to Market Perform from Underperform at BMO Capital » 04:58
06/18/21
06/18
04:58
06/18/21
04:58
NHI

National Health Investors

$65.59 /

-0.29 (-0.44%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NHI National Health Investors
$65.59 /

-0.29 (-0.44%)

NHI National Health Investors
$65.59 /

-0.29 (-0.44%)

04/05/21 Wells Fargo
National Health Investors price target raised to $74 from $66 at Wells Fargo
03/30/21 Capital One
National Health Investors downgraded to Equalweight from Overweight at Capital One
03/23/21 Truist
National Health Investors price target raised to $74 from $69 at Truist
01/13/21 Mizuho
National Health downgraded to Underperform with $55 target at Mizuho
NHI National Health Investors
$65.59 /

-0.29 (-0.44%)

NHI National Health Investors
$65.59 /

-0.29 (-0.44%)

Initiation
Paysafe initiated with an Outperform at BMO Capital » 04:57
06/18/21
06/18
04:57
06/18/21
04:57
PSFE

Paysafe

$11.38 /

+0.16 (+1.43%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSFE Paysafe
$11.38 /

+0.16 (+1.43%)

PSFE Paysafe
$11.38 /

+0.16 (+1.43%)

06/01/21
Fly Intel: Top five analyst initiations
06/01/21 Susquehanna
Susquehanna starts Paysafe with Positive rating, $17 price target
06/01/21 Susquehanna
Paysafe initiated with a Positive at Susquehanna
05/26/21 Evercore ISI
Paysafe initiated with an Outperform at Evercore ISI
PSFE Paysafe
$11.38 /

+0.16 (+1.43%)

PSFE Paysafe
$11.38 /

+0.16 (+1.43%)

PSFE Paysafe
$11.38 /

+0.16 (+1.43%)

Recommendations
Adobe price target raised to $660 from $630 at Jefferies » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
ADBE

Adobe

$551.22 /

+8.16 (+1.50%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

06/14/21 Jefferies
Adobe price target raised to $630 from $560 at Jefferies
05/24/21 Mizuho
Mizuho starts digital creativity and productivity 'titan' Adobe at Buy
05/24/21 Mizuho
Adobe initiated with a Buy at Mizuho
05/18/21 Jefferies
Adobe price target lowered to $560 from $610 at Jefferies
ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

ADBE Adobe
$551.22 /

+8.16 (+1.50%)

Conference/Events
UBS healthcare analyst to hold an analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
UBS consumer goods/services analysts to hold analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Smith & Wesson Brands to hold virtual analyst day » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
SWBI

Smith & Wesson Brands

$19.93 /

-0.62 (-3.02%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 Lake Street
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street
03/05/21 Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
03/05/21 Craig-Hallum
Smith & Wesson Brands downgraded to Hold from Buy at Craig-Hallum
SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

SWBI Smith & Wesson Brands
$19.93 /

-0.62 (-3.02%)

Conference/Events
Iveric bio to hold a webinar » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
ISEE

Iveric bio

$5.87 /

-0.07 (-1.18%)

Dry Age-Related Macular…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ISEE Iveric bio
$5.87 /

-0.07 (-1.18%)

08/13/20 Credit Suisse
Iveric bio initiated with an Outperform at Credit Suisse
ISEE Iveric bio
$5.87 /

-0.07 (-1.18%)

Conference/Events
Haemonetics participates in a conference call with Morgan Stanley » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
HAE

Haemonetics

$62.58 /

+3.68 (+6.25%)

MedTech Analyst Ranieri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$62.58 /

+3.68 (+6.25%)

HAE Haemonetics
$62.58 /

+3.68 (+6.25%)

06/17/21 Citi
Haemonetics initiated with a Buy at Citi
05/14/21 CJS Securities
Haemonetics upgraded to Outperform from Market Perform at CJS Securities
05/14/21 Jefferies
Haemonetics price target lowered to $85 from $105 at Jefferies
05/14/21 Barrington
Haemonetics price target lowered to $71 from $91 at Barrington
HAE Haemonetics
$62.58 /

+3.68 (+6.25%)

HAE Haemonetics
$62.58 /

+3.68 (+6.25%)

Conference/Events
UBS financials/fintech analysts to hold analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Financials & FinTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Jefferies interactive entertainment analyst has analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Interactive Entertainment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Porch.com participates in a conference call with Stephens » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
PRCH

Porch.com

$18.12 /

+0.06 (+0.33%)

Real Estate Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

05/14/21 Cantor Fitzgerald
Porch.com initiated with an Overweight at Cantor Fitzgerald
05/11/21
Fly Intel: Top five analyst initiations
05/11/21 Stephens
Porch.com initiated with an Overweight at Stephens
03/26/21 Craig-Hallum
Porch.com initiated with a Buy at Craig-Hallum
PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

PRCH Porch.com
$18.12 /

+0.06 (+0.33%)

Conference/Events
Alkermes participates in a conference call with Mizuho » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
ALKS

Alkermes

$24.68 /

-0.4 (-1.60%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALKS Alkermes
$24.68 /

-0.4 (-1.60%)

ALKS Alkermes
$24.68 /

-0.4 (-1.60%)

06/07/21 Mizuho
Alkermes oncology asset underappreciated by investors, says Mizuho
06/02/21 H.C. Wainwright
Alkermes price target raised to $25 from $24 at H.C. Wainwright
06/01/21 Goldman Sachs
Goldman keeps Sell on Alkermes, says Lybalvi not 'practice changing'
04/29/21 H.C. Wainwright
Alkermes price target raised to $24 from $23 at H.C. Wainwright
ALKS Alkermes
$24.68 /

-0.4 (-1.60%)

ALKS Alkermes
$24.68 /

-0.4 (-1.60%)

ALKS Alkermes
$24.68 /

-0.4 (-1.60%)

Conference/Events
Brady to host conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
BRC

Brady

$56.37 /

-2.075 (-3.55%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRC Brady
$56.37 /

-2.075 (-3.55%)

BRC Brady
$56.37 /

-2.075 (-3.55%)

06/08/21 Wells Fargo
Wells Fargo double upgrades Brady on 'business transformation catalysts'
06/08/21 Wells Fargo
Brady upgraded to Overweight from Underweight at Wells Fargo
12/18/20 Sidoti
Brady reinstated with a Buy at Sidoti
08/28/20 Northcoast
Brady upgraded to Buy from Neutral at Northcoast
BRC Brady
$56.37 /

-2.075 (-3.55%)

Conference/Events
Cowen medical devices analyst to hold analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Cowen Medical Devices…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Medtronic participates in a conference call with JPMorgan » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
MDT

Medtronic

$125.25 /

+0.195 (+0.16%)

Medical Supplies &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$125.25 /

+0.195 (+0.16%)

MDT Medtronic
$125.25 /

+0.195 (+0.16%)

06/10/21 Truist
Aziyo Biologics price target lowered to $16 from $20 at Truist
06/07/21 Piper Sandler
Piper cuts Aziyo target but sees Medtronic sticking with company
06/03/21 Piper Sandler
Piper stays Overweight Medtronic after HeartWare HVAD device discontinued
06/03/21 Argus
Medtronic price target raised to $150 from $135 at Argus
MDT Medtronic
$125.25 /

+0.195 (+0.16%)

MDT Medtronic
$125.25 /

+0.195 (+0.16%)

Conference/Events
Fresenius Medical management to meet virtually with Oppenheimer » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
FMS

Fresenius Medical

$41.97 /

-0.01 (-0.02%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

05/12/21 Nord/LB
Fresenius Medical upgraded to Buy from Hold at Nord/LB
05/10/21 Credit Suisse
Fresenius Medical price target raised to EUR 68 from EUR 62 at Credit Suisse
04/28/21 Barclays
Fresenius Medical price target lowered to EUR 78 from EUR 85 at Barclays
03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
FMS Fresenius Medical
$41.97 /

-0.01 (-0.02%)

Conference/Events
Aviat Networks management to meet virtually with Northland » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
AVNW

Aviat Networks

$41.11 /

-0.43 (-1.04%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVNW Aviat Networks
$41.11 /

-0.43 (-1.04%)

AVNW Aviat Networks
$41.11 /

-0.43 (-1.04%)

02/04/21 Northland
Aviat Networks price target raised to $57 from $40 at Northland
08/28/20 Northland
Aviat Networks price target raised to $27 from $20 at Northland
AVNW Aviat Networks
$41.11 /

-0.43 (-1.04%)

AVNW Aviat Networks
$41.11 /

-0.43 (-1.04%)

AVNW Aviat Networks
$41.11 /

-0.43 (-1.04%)

Conference/Events
Moderna participates in a conference call with JPMorgan » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
MRNA

Moderna

$202.41 /

+4.57 (+2.31%)

Large Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$202.41 /

+4.57 (+2.31%)

MRNA Moderna
$202.41 /

+4.57 (+2.31%)

06/16/21 Piper Sandler
Piper reiterates Overweight rating on Moderna after U.S. orders 200M more doses
06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
MRNA Moderna
$202.41 /

+4.57 (+2.31%)

MRNA Moderna
$202.41 /

+4.57 (+2.31%)

MRNA Moderna
$202.41 /

+4.57 (+2.31%)

MRNA Moderna
$202.41 /

+4.57 (+2.31%)

Conference/Events
AtriCure management to meet virtually with Oppenheimer » 04:55
06/18/21
06/18
04:55
06/18/21
04:55
ATRC

AtriCure

$77.40 /

+1.44 (+1.90%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRC AtriCure
$77.40 /

+1.44 (+1.90%)

ATRC AtriCure
$77.40 /

+1.44 (+1.90%)

06/15/21 Stifel
AtriCure price target raised to $85 from $72 at Stifel
05/26/21 SVB Leerink
AtriCure price target raised to $95 from $78 at SVB Leerink
05/14/21 JPMorgan
AtriCure price target raised to $81 from $70 at JPMorgan
04/30/21 Canaccord
AtriCure price target raised to $102 from $77 at Canaccord
ATRC AtriCure
$77.40 /

+1.44 (+1.90%)

Conference/Events
UBS consumer goods analyst to hold analyst/industry conference call » 04:55
06/18/21
06/18
04:55
06/18/21
04:55

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
CureVac data 'leaves the spot open' for Altimmune, says Piper Sandler » 04:52
06/18/21
06/18
04:52
06/18/21
04:52
ALT

Altimmune

$15.88 /

-0.55 (-3.35%)

, CVAC

CureVac

$57.80 /

-36.9 (-38.97%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$15.88 /

-0.55 (-3.35%)

CVAC CureVac
$57.80 /

-36.9 (-38.97%)

ALT Altimmune
$15.88 /

-0.55 (-3.35%)

06/16/21 JMP Securities
Altimmune price target raised to $53 from $45 at JMP Securities
06/16/21 H.C. Wainwright
H.C. Wainwright says Altimmune has 'potential blockbuster indication' in obesity
06/16/21 Piper Sandler
Altimmune weight loss data 'outstanding,' says Piper Sandler
06/02/21 H.C. Wainwright
Altimmune initiated with a Buy at H.C. Wainwright
CVAC CureVac
$57.80 /

-36.9 (-38.97%)

06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Guggenheim
CureVac fair value drops to $15-$30 from $90-$110 after failure, says Guggenheim
06/17/21 BofA
CureVac cut to Neutral at BofA after disappointing COVID vaccine data
06/17/21 BofA
CureVac downgraded to Neutral from Buy at BofA
ALT Altimmune
$15.88 /

-0.55 (-3.35%)

  • 28
    Jan
  • 14
    Aug
  • 14
    Jul
ALT Altimmune
$15.88 /

-0.55 (-3.35%)

CVAC CureVac
$57.80 /

-36.9 (-38.97%)

ALT Altimmune
$15.88 /

-0.55 (-3.35%)

CVAC CureVac
$57.80 /

-36.9 (-38.97%)

CVAC CureVac
$57.80 /

-36.9 (-38.97%)

Upgrade
Lennar upgraded to Overweight from Neutral at JPMorgan » 04:47
06/18/21
06/18
04:47
06/18/21
04:47
LEN

Lennar

$94.57 /

+3.09 (+3.38%)

JPMorgan analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEN Lennar
$94.57 /

+3.09 (+3.38%)

LEN Lennar
$94.57 /

+3.09 (+3.38%)

06/17/21 Wells Fargo
Lennar stock should react positively after quarterly results, says Wells Fargo
04/15/21 Wells Fargo
Lennar initiated with an Equal Weight at Wells Fargo
03/18/21 RBC Capital
Lennar price target raised to $97 from $93 at RBC Capital
03/18/21 BTIG
Lennar price target raised to $117 from $104 at BTIG
LEN Lennar
$94.57 /

+3.09 (+3.38%)

LEN Lennar
$94.57 /

+3.09 (+3.38%)

LEN Lennar
$94.57 /

+3.09 (+3.38%)

LEN Lennar
$94.57 /

+3.09 (+3.38%)

Downgrade
Compass Minerals downgraded to Underweight from Neutral at JPMorgan » 04:47
06/18/21
06/18
04:47
06/18/21
04:47
CMP

Compass Minerals

$61.76 /

-2.51 (-3.91%)

JPMorgan analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMP Compass Minerals
$61.76 /

-2.51 (-3.91%)

CMP Compass Minerals
$61.76 /

-2.51 (-3.91%)

12/14/20
Fly Intel: Top five analyst downgrades
12/14/20 Monness Crespi
Compass Minerals downgraded to Neutral from Buy at Monness Crespi
12/10/20 Credit Suisse
Compass Minerals downgraded to Underperform on valuation at Credit Suisse
12/10/20 Credit Suisse
Compass Minerals downgraded to Underperform from Neutral at Credit Suisse
CMP Compass Minerals
$61.76 /

-2.51 (-3.91%)

CMP Compass Minerals
$61.76 /

-2.51 (-3.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.